$HAO jumped 22% on 14 August, and someone asked us whether it is a dead stock.
It is not dead. It is a financing machine, and the filings are unusually blunt about it: shareholders have authorised up to 100 trillion Class A shares and given the board power to reverse-split up to 1-for-8,000 at its own discretion until 2028.
There are 366,126 shares outstanding. The whole company is worth $1.46 million.
What caused the 22%
Not news. The split itself.
On 14 August the stock consolidated 1-for-20, so the tradeable count fell twentyfold overnight. Our raw series shows $0.1627 to $3.98, but almost all of that is arithmetic. The real move was +22% on 1,083,634 shares, which is what happens when the same order flow meets a float twenty times smaller.
No earnings, no contract, no announcement.
Is day two usually better? No.
We measured it rather than guessed. Across 186 one-off reverse splits in 2026, here is what happened from the split-day close:
| Trading day after | Sample | Average return | Share that finished higher |
|---|---|---|---|
| +1 | 174 | -7.2% | 33% |
| +2 | 166 | -8.1% | 30% |
| +3 | 164 | -8.5% | 29% |
| +5 | 154 | -6.7% | 31% |
Roughly two in three are lower the next day, and the average sits 7% to 8% below the split close for a week.
That is a base rate, not a forecast for this ticker. But it is the honest starting point, and it is the opposite of what a green 22% candle suggests.
Why the supply gets worse if the price goes up
Two offerings since May, both structured the same way: shares plus pre-funded warrants, which are shares in all but name.
| Date | Sold | Warrants attached |
|---|---|---|
| 11 May 2026 | 9,000,000 shares at $0.25 | 16,999,998, convertible into up to 176,034,979 shares |
| 10 July 2026 | 300,000 shares at $0.40 | 9,700,000 more |
Those holders are currently underwater. Their break-evens in today's consolidated shares are $5.00 and $8.00, against $3.98. So nothing compels them to convert right now.
Which makes those prices a ceiling, not a floor.
Above $5.00 the May buyers are in profit; above $8.00 the July buyers are too. Converting and selling is then the only way to realise a gain on an instrument that pays no dividend and carries no vote. That is roughly 8.8 million share-equivalents against 366,126 shares outstanding, about 24 times the float, waiting on a price rather than a date.
A rally does not risk bringing supply. It is the mechanism that creates it.
When the next offering is likely
| Year to 30 June | Cash burned by operations | Raised from financing |
|---|---|---|
| 2024 | -$747,576 | +$9,323,557 |
| 2025 | -$3,358,082 | +$8,902,467 |
The burn more than quadrupled, but the useful point is that this company has never funded itself from operations. Financing has exceeded the operating burn every year by $6m to $8.5m.
So it does not raise because it is about to run out. It raises because that is the model. The recent cadence, 11 May and 10 July, sixty days apart, puts the next round near September 2026, and every authorisation it needs is already granted.
Who actually owns it
Almost nobody. Institutions hold 0.51%. There are no insider transactions on record at all, in either direction, so nobody inside has bought a share on the open market. The float is 99.5% of the company: nothing is locked up and nothing is being held back.
Control is not in play regardless. Class B carries 30 votes per share, so 317,897 shares hold 83.4% of the votes against 1,904,632 Class A on one vote each. Every offering sells Class A. The shares being diluted are not the shares that decide anything.
The bull case, stated fairly
There is one, and it is thinner than the bear case but it is real.
The revenue is not fake. Haoxi booked $32,804,336 in the year to June 2025 buying and reselling healthcare advertising. A working business with customers, valued today at $1.46 million.
No supply is being forced out right now. The warrant holders are underwater, so the pressure is voluntary and price-triggered rather than scheduled.
And it is not about to fail for lack of cash. It has raised more than it burned every year. Running out of money next month is not the risk here.
Set against that: revenue fell 32% in the most recent audited year, gross margin halved to 2.8%, and operating income turned into a $1,999,903 loss. The reported net profit of $3,876,680 came from a $6,761,463 non-cash gain on revaluing its own warrants, which only happens when the share price falls. The profit exists because the stock collapsed.
Those figures are from June 2025. Haoxi reports annually, so the next audited look is the FY2026 report due around October.
One number of ours that was wrong
Our original post said "38% of all shares outstanding are sold short." Dividing 140,665 short shares by 366,126 gives 38.4%, but the short interest is a pre-consolidation count and the share count is post-consolidation. On one basis it is about 1.9%. We have posted a correction, and the code now refuses that ratio when the share basis has changed. There is no squeeze here.
What to watch
- The share count on the next filing. If it climbs, warrants are converting.
- $5.00 and $8.00. The levels that turn holders into sellers.
- September, on the sixty-day cadence.
- The FY2026 report, around October, and the first audited numbers in fourteen months.
This is not advice and it is not a price target. It is what the filings say, and they are clearer than usual about what comes next.